"Save the date: INFARMED Hosts Final Symposium of the European Project Real4Reg | 3 e 4 de novembro de 2026 Can regulatory and health technology assessment (HTA) decision-making be optimised through the use of real-world data (RWD) and artificial intelligence (AI) methods? This was the core research question of the European project Real4Reg, an innovative initiative funded by the European Union and coordinated by the German Federal Institute for Drugs and Medical Devices (BfArM). This project aimed to enable the use, establish the value, and impact RWD use and analyses in regulatory and HTA decision-making, through the development of AI methods. For more information, click here. The project’s results, lessons learnt, and insights on how RWD can impact decision-making will be shared on a Final Symposium, hosted by INFARMED, I.P. on 3-4 November 2026. The agenda includes the following sections: results of each research topic (breast cancer, amyotrophic lateral sclerosis, fluoroquinolones,..."